KR20230154789A - 헤테로고리 메탄온 화합물 및 그의 아자-비시클로 중간체의 제조 공정 - Google Patents

헤테로고리 메탄온 화합물 및 그의 아자-비시클로 중간체의 제조 공정 Download PDF

Info

Publication number
KR20230154789A
KR20230154789A KR1020237018659A KR20237018659A KR20230154789A KR 20230154789 A KR20230154789 A KR 20230154789A KR 1020237018659 A KR1020237018659 A KR 1020237018659A KR 20237018659 A KR20237018659 A KR 20237018659A KR 20230154789 A KR20230154789 A KR 20230154789A
Authority
KR
South Korea
Prior art keywords
formula
compound
group
manufacturing process
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237018659A
Other languages
English (en)
Korean (ko)
Inventor
크리스티안 그루겔
토비아스 웨델
Original Assignee
액티노젠 메디컬 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2020904060A external-priority patent/AU2020904060A0/en
Application filed by 액티노젠 메디컬 리미티드 filed Critical 액티노젠 메디컬 리미티드
Publication of KR20230154789A publication Critical patent/KR20230154789A/ko
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B49/00Grignard reactions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020237018659A 2020-11-06 2021-11-05 헤테로고리 메탄온 화합물 및 그의 아자-비시클로 중간체의 제조 공정 Pending KR20230154789A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020904060A AU2020904060A0 (en) 2020-11-06 Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof
AU2020904060 2020-11-06
PCT/AU2021/051310 WO2022094668A1 (en) 2020-11-06 2021-11-05 Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof

Publications (1)

Publication Number Publication Date
KR20230154789A true KR20230154789A (ko) 2023-11-09

Family

ID=81458249

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237018659A Pending KR20230154789A (ko) 2020-11-06 2021-11-05 헤테로고리 메탄온 화합물 및 그의 아자-비시클로 중간체의 제조 공정

Country Status (11)

Country Link
US (1) US20230416243A1 (https=)
EP (1) EP4240740A4 (https=)
JP (1) JP2023548368A (https=)
KR (1) KR20230154789A (https=)
CN (1) CN116981461A (https=)
AU (1) AU2021374232A1 (https=)
CA (1) CA3196642A1 (https=)
CL (1) CL2023001300A1 (https=)
IL (1) IL302671A (https=)
MX (1) MX2023004940A (https=)
WO (1) WO2022094668A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026509196A (ja) * 2023-03-02 2026-03-17 アクチノゲン メディカル リミテッド アザ二環式ヘテロアリール化合物を調製するための流動化学プロセス
WO2025073002A1 (en) * 2023-10-03 2025-04-10 Actinogen Medical Limited Tablet formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410961B2 (en) * 2004-01-20 2008-08-12 Merck & Co., Inc. 2,6-disubstituted piperiddines as modulators
MY145633A (en) * 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
ES2366058T3 (es) * 2006-03-01 2011-10-14 Theravance, Inc. Compuestos de 8-azabiciclo[3.2.1]octano como antagonistas de los receptores opioides mu.
AR073920A1 (es) * 2008-10-23 2010-12-09 Boehringer Ingelheim Int Derivados urea de nortropanos sustituidos, medicamentos que contienen dichos compuestos , su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa y proceso para su preparacion.
US8642621B2 (en) * 2009-09-16 2014-02-04 The University Of Edinburgh (4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use
KR101445012B1 (ko) * 2009-12-17 2014-09-26 머크 샤프 앤드 돔 코포레이션 Syk 억제제로서의 아미노피리미딘
EP2525659B1 (en) * 2010-01-19 2019-02-27 Merck Sharp & Dohme Corp. PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
AU2011247116B2 (en) * 2010-04-29 2015-12-03 The University Of Edinburgh 3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1] oct- 8 - yl) -[5- (1H - pyrazol - 4 -yl) -thiophen-3 -yl] methanones as inhibitors of 11 (beta) -HSD1

Also Published As

Publication number Publication date
US20230416243A1 (en) 2023-12-28
WO2022094668A1 (en) 2022-05-12
IL302671A (en) 2023-07-01
MX2023004940A (es) 2023-09-12
CN116981461A (zh) 2023-10-31
CL2023001300A1 (es) 2024-01-05
AU2021374232A1 (en) 2023-06-08
EP4240740A4 (en) 2024-12-11
JP2023548368A (ja) 2023-11-16
CA3196642A1 (en) 2022-05-12
EP4240740A1 (en) 2023-09-13
AU2021374232A9 (en) 2024-09-26

Similar Documents

Publication Publication Date Title
EP3450439B1 (en) Method for producing monomer for single-stranded nucleic acid molecule
CN118871436A (zh) 可用作抗癌剂的吡唑基衍生物的合成方法
TW201713652A (zh) 雜環化合物的合成
AU2010289802C1 (en) Synthesis of a neurostimulative piperazine
EP3766869B1 (en) Simple preparation method for avibactam
ES2769255T3 (es) Métodos para fabricar inhibidores de la proteína desacetilasa
US11926633B2 (en) Synthesis methods for upadacitinib and intermediate thereof
KR20230154789A (ko) 헤테로고리 메탄온 화합물 및 그의 아자-비시클로 중간체의 제조 공정
JP2020506161A (ja) 5r−ベンジルオキシアミノピペリジン−2s−ギ酸又はその誘導体の調製方法
KR102593509B1 (ko) 질소 머스타드 유도체의 제조 방법
WO2024069507A1 (en) Synthesis methods and intermediates for the production of remibrutinib
CN111943893B (zh) 4,7-二氮杂螺[2,5]辛烷类化合物的合成方法
CN104876872A (zh) 一种制备1-叔丁氧基羰基-3-羟甲基吲唑的方法及应用
EP4259626B1 (en) Process for the preparation 4-(3,5-difluorophenyl)-n-[3-(6-methylpyrimidin-4-yl)-3- azabicyclo[3.2.1]octan-8-yl]-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine
CA3268617A1 (en) Synthesis methods and intermediates
KR20240122751A (ko) 바이사이클릭 글리신-프롤린 화합물 및 이의 모노사이클릭 글리신-프롤린 중간체를 제조하는 방법
CN110573521B (zh) 4’-硫代核苷的新型化合物的制备方法和此制备方法中的中间体
WO2025240628A1 (en) Processes for preparing a pkc inhibitor
WO2013140331A1 (en) New 1, 2, 4-oxadiazol derivatives, process for their preparation and use thereof as intermediates in the preparation of indolic alkaloids
JP2025156267A (ja) エロビキシバット又はその溶媒和物の調製のための方法
Kaiser et al. Formation of N-acyl-N, N′-dicyclohexylureas from DCC and Arenecarboxylic Acids in the Presence of Hydroxybenzotriazole in CH2Cl2 at Room Temperature
WO2026082013A1 (zh) 一种酞嗪酮类prmt5抑制剂及其中间体的制备方法
CN119638647A (zh) 制备氧杂环丁烷-2-基甲胺或其盐的方法
CN117736221A (zh) 瑞卢戈利中间体化合物及瑞卢戈利的制备方法
WO2015031562A1 (en) PROCESS FOR THE PREPARATION OF N,N-DICYCLOPROPYL-4-(1,5-DIMETHYL-1H-PYRAZOL-3-YLAMINO)-6-ETHYL-1-METHYL-1,6-DIHYDROIMIDAZO[4,5-d]PYRROLO[2,3-b]PYRIDINE-7-CARBOXAMIDE

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230601

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20241029

Comment text: Request for Examination of Application